Cigna Prior Authorization Lookup
Latest Cigna prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Amondys 45This policy governs prior authorization and medical necessity for Amondys 45 (casimersen intravenous infusion) for patients with Duchenne muscular dystrophy. It applies to providers requesting prescription benefit coverage and requires specified clinical documentation, specialist involvement, and dosing.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Antibiotics (Inhaled) - ArikaycePrior authorization and medical-necessity coverage for Arikayce in adults with refractory MAC lung disease and for cystic fibrosis-associated Pseudomonas aeruginosa infection, subject to specified clinical and specialist-treatment criteria.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Antiseizure Medications - Clobazam ProductsThis policy governs prior authorization and medical-necessity coverage for clobazam products, including Onfi, generic clobazam, and Sympazan, for commercially insured members. It applies to initial and continuation therapy for Lennox-Gastaut syndrome, Dravet syndrome, and treatment-refractory seizures or epilepsy.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15AqneursaThis Cigna drug coverage policy governs prior authorization and benefit coverage for Aqneursa (levacetylleucine oral suspension). It applies to health benefit plans administered by Cigna Companies, subject to the member's specific benefit plan, applicable law, and the clinical criteria in the policy.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Bimzelx Prior Authorization PolicyPrior authorization and medical-necessity criteria for Bimzelx in adults with ankylosing spondylitis, hidradenitis suppurativa, non-radiographic axial spondyloarthritis, plaque psoriasis, or psoriatic arthritis.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Bone Modifiers - EvenityThis policy governs prior authorization and medical-benefit coverage of Evenity for postmenopausal patients with osteoporosis. Coverage requires specified clinical severity, prior-treatment or exception criteria, dosing limits, and covered HCPCS coding.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Bone Modifiers - Teriparatide ProductsThis policy governs prior authorization and medical-necessity coverage for Bonsity, Forteo, and teriparatide subcutaneous injections. It applies to Cigna-administered health benefit plans and establishes indication-specific clinical, prior-treatment, duration, and preferred-product requirements.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Bone Modifiers - TymlosThis policy governs prior authorization and medical necessity coverage for Tymlos subcutaneous injection for osteoporosis treatment in postmenopausal patients and men. Coverage is subject to the member's benefit plan, applicable law, and the clinical criteria in this policy.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Botulinum Toxins - DaxxifyThis policy governs prior authorization and benefit coverage for Daxxify administered for cervical dystonia in adults. It establishes medical-necessity criteria, dosing limits, documentation requirements, noncovered cosmetic uses, and applicable billing code requirements.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Botulinum Toxins - MyoblocThis policy governs benefit coverage and prior authorization for Myobloc (rimabotulinumtoxinB injection) administered under Cigna health benefit plans. Coverage is subject to the applicable benefit plan, covered diagnoses and codes, documented medical-necessity criteria, and dosing requirements.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Chelating Agent - Edetate Calcium DisodiumCoverage and prior authorization for edetate calcium disodium for medically necessary treatment of acute or chronic lead poisoning, including lead encephalopathy, subject to indication and dosing criteria.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Colony Stimulating Factors - RyzneutaCoverage of Ryzneuta for adults with non-myeloid malignancies receiving myelosuppressive chemotherapy and for hematopoietic acute radiation syndrome, including prior authorization, clinical criteria, dosing, specialist prescribing, preferred-product requirements, and noncovered uses.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Denosumab Products (Prolia) Prior AuthorizationThis policy governs prior authorization and medical-necessity coverage for Prolia and specified denosumab biosimilars used to treat osteoporosis or cancer-treatment-related bone loss. It applies to health benefit plans administered by Cigna Companies, subject to the member’s benefit plan, applicable law, and any controlling coverage mandate.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15ExdensurPrior authorization and benefit coverage for Exdensur (depemokimab-ulaa) subcutaneous injection in adults and pediatric patients aged 12 years and older with severe eosinophilic asthma, subject to clinical, specialist, preferred-product, continuation, dosing, and coding criteria.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Exondys 51This policy governs prior authorization and medical-necessity coverage for Exondys 51 (eteplirsen intravenous infusion) for patients with Duchenne muscular dystrophy. Coverage applies when the genetic, functional, age, specialist-prescribing, dosing, and other policy criteria are met.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Fish Oil Triglycerides - OmegavenThis policy governs prior authorization and benefit coverage for Omegaven under Cigna-administered health benefit plans, including coverage for pediatric patients under 18 years of age with established parenteral nutrition-associated cholestasis (PNAC), subject to applicable plan terms and policy criteria.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Growth Disorders - Ngenla Prior Authorization PolicyThis policy governs coverage and prior authorization for Ngenla (somatrogon-ghla) for pediatric patients with growth failure due to inadequate growth hormone secretion, subject to the member’s benefit plan, applicable law, and the policy’s clinical and coding requirements.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Growth Disorders Growth Hormone Short-Acting Products Preferred Specialty Management PolicyThis policy governs preferred-product selection and exception review for short-acting somatropin products under Cigna-administered health benefit plans. Patients must meet the applicable standard prior authorization criteria, and non-preferred products generally require prior trial and intolerance of preferred products.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hematology - AphexdaThis policy governs prior authorization and medical-necessity coverage for Aphexda (motixafortide) used with filgrastim to mobilize hematopoietic stem cells for collection and subsequent autologous transplantation in adults with multiple myeloma. It applies to providers submitting pharmacy benefit requests under applicable Cigna-administered plans.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hepatology - GivlaariThis policy governs prior authorization and benefit coverage for Givlaari (givosiran) for patients with acute hepatic porphyria, subject to the applicable benefit plan, laws, and individual clinical circumstances.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hereditary Angioedema - C1 Esterase Inhibitors (Subcutaneous)This policy governs prior authorization and medical-necessity coverage for Haegarda (subcutaneous C1 esterase inhibitor [human]) used for routine prophylaxis of hereditary angioedema due to C1-INH deficiency. It applies to Cigna-administered health benefit plans, subject to the applicable benefit plan document and laws.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hereditary Angioedema - KalbitorThis policy governs prior authorization and medical-necessity coverage for Kalbitor (ecallantide) subcutaneous injection for acute attacks of hereditary angioedema due to C1-inhibitor deficiency.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hereditary Angioedema - TakhzyroThis policy governs prior authorization and benefit coverage for Takhzyro (lanadelumab-flyo) used to prevent attacks of hereditary angioedema due to C1-inhibitor deficiency. It applies to health benefit plans administered by Cigna, subject to the applicable benefit plan, laws, and individual clinical circumstances.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15Hypertriglyceridemia - RedemploThis policy governs prior authorization and medical-necessity coverage for Redemplo (plozasiran subcutaneous injection) in adults with familial chylomicronemia syndrome. It applies to health benefit plans administered by Cigna Companies, subject to the applicable benefit plan terms and coverage mandates.All Cigna updates
- Prior AuthClinical/Medical PolicyEff. 2026-11-15IvabradineThis policy governs prior authorization and medical necessity coverage for Corlanor (ivabradine tablets and oral solution) and generic ivabradine tablets for adult heart failure, pediatric heart failure due to dilated cardiomyopathy, and inappropriate sinus tachycardia under applicable Cigna benefit plans.All Cigna updates
Tool Description
Search Cignaprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.